Evidence map›Paper›PMID 19585568›Full record

ArticleJournal of biomedical materials research. Part A2010

Interplay of anionic charge, poly(ethylene glycol), and iodinated tyrosine incorporation within tyrosine-derived polycarbonates: Effects on vascular smooth muscle cell adhesion, proliferation, and motility.

Patrick A Johnson, Arnold Luk, Aleksey Demtchouk, Hiral Patel, Hak-Joon Sung, Matthew D Treiser, Simon Gordonov, Larisa Sheihet, Das Bolikal, Joachim Kohn and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of biomedical materials research. Part A, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Intraocular Implants for the Treatment of Autoimmune Uveitis.Journal of functional biomaterials · 2015
    Review
  3. Molecular design and evaluation of biodegradable polymers using a statistical approach.Journal of materials science. Materials in medicine · 2013
    Article
  4. Article
  5. Biomedical Applications of Biodegradable Polymers.Journal of polymer science. Part B, Polymer physics · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Patrick A JohnsonDepartment of Chemical and Biochemical Engineering, Rutgers University, Piscataway, New Jersey 08854, USA.
Arnold Luk
Aleksey Demtchouk
Hiral Patel
Hak-Joon Sung
Matthew D Treiser
Simon Gordonov
Larisa Sheihet
Das Bolikal
Joachim Kohn
Prabhas V Moghe
Rutgers, The State University of New Jersey · US

Funding

RESBIO - the Technology Resource for Polymeric BiomaterialsP41EB001046 · NIBIB · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI KOHN, JOACHIM B. · 2003 to 2017
$17.0M
TRAINING IN TISSUE ENGINEERING &IMPLANT SCIENCET32HL007942 · NHLBI · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI KOHN, JOACHIM B. · 2000 to 2004
$816k
NHLBI NIH HHS T32 HL007942NHLBI NIH HHS T32 HL-07942NIBIB NIH HHS P41 EB001046
6 · The paper itself

Abstract

Regulation of smooth muscle cell adhesion, proliferation, and motility on biomaterials is critical to the performance of blood-contacting implants and vascular tissue engineering scaffolds. The goal of this study was to examine the underlying substrate-smooth muscle cell response relations, using a selection of polymers representative of an expansive library of multifunctional, tyrosine-derived polycarbonates. Three chemical components within the polymer structure were selectively varied through copolymerization: (1) the content of iodinated tyrosine to achieve X-ray visibility; (2) the content of poly(ethylene glycol) (PEG) to decrease protein adsorption and cell adhesivity; and (3) the content of desaminotyrosyl-tyrosine (DT), which regulates the rate of polymer degradation. Using quartz crystal microbalance with dissipation, we quantified differential serum protein adsorption behavior because of the chemical components DT, iodinated tyrosine, and PEG: increased PEG content within the polymer structure progressively decreased protein adsorption but the simultaneous presence of both DT and iodinated tyrosine reversed the effects of PEG. The complex interplay of these components was next tested on the adhesion, proliferation, and motility behavior cultured human aortic smooth muscle cells. The incorporation of PEG into the polymer reduced cell attachment, which was reversed in the presence of iodinated tyrosine. Further, we found that as little as 10% DT content was sufficient to negate the PEG effect in polymers containing iodinated tyrosine, whereas in non-iodinated polymers, the PEG effect on cell attachment was reversed. Cross-functional analysis of motility and proliferation revealed divergent substrate chemistry related cell response regimes. For instance, within the series of polymers containing both iodinated tyrosine and 10% of DT, increasing PEG levels lowered smooth muscle cell motility without a change in the rate of cell proliferation. In contrast, for non-iodinated tyrosine and 10% of DT, increasing PEG levels increased cell proliferation significantly while reducing cell motility. Clearly, the polycarbonate polymer library offers a sensitive platform to modulate cell adhesion, proliferation, and motility responses, which, in turn, may have implications for controlling vascular remodeling in vivo. Additionally, our data suggests unique biorelevant properties following the incorporation of iodinated subunits in a polymeric biomaterial as a potential platform for X-ray visible devices.

Indexed as

Polycarboxylate CementAdsorptionAnionsBiocompatible MaterialsCell AdhesionCell MovementCell ProliferationCells, CulturedCell ShapeHumansIodineMaterials TestingMolecular StructureMuscle, Smooth, VascularMyocytes, Smooth MusclePolyethylene GlycolsAnionsBiocompatible MaterialsIodinepolycarbonatePolycarboxylate CementPolyethylene GlycolsTyrosine

Identifiers

PMID19585568
PMCPMC2845728
OpenAlexW2076910853

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.